<DOC>
	<DOCNO>NCT01755286</DOCNO>
	<brief_summary>The purpose study describe safety tolerability two dose level OTO-201 , placebo sham administer intra-operatively pediatric subject bilateral middle ear effusion require tympanostomy tube placement .</brief_summary>
	<brief_title>OTO-201 Middle Ear Effusion Pediatric Subjects Requiring Tympanostomy Tube Placement</brief_title>
	<detailed_description />
	<mesh_term>Otitis Media Effusion</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<criteria>Inclusion Criteria include , limited : Subject male female age 6 month 12 year , inclusive Subject clinical diagnosis bilateral middle ear effusion require tympanostomy tube placement Subject 's caregiver willing comply protocol attend study visit Exclusion Criteria include , limited : Subject history prior ear mastoid surgery , include myringotomy myringotomy tympanostomy tube placement Subject history sensorineural hearing loss Subject history chronic recurrent bacterial infection otitis medium likely require treatment antibiotic course study</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>